These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 32079950)

  • 1. Commercial Interests in Continuing Medical Education: Where Do Electronic Health Record Vendors Fit?
    Rubinstein PF; Middleton B; Goodman KW; Lehmann CU
    Acad Med; 2020 Nov; 95(11):1674-1678. PubMed ID: 32079950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmaceutical industry financial support for medical education: benefit, or undue influence?
    Brody H
    J Law Med Ethics; 2009; 37(3):451-60, 396. PubMed ID: 19723256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The uncertain future of continuing medical education: commercialism and shifts in funding.
    Van Harrison R
    J Contin Educ Health Prof; 2003; 23(4):198-209. PubMed ID: 14730790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. It is time to study the costs and benefits of regulating continuing medical education in the United States.
    Mazmanian PE
    J Contin Educ Health Prof; 2009; 29(4):197-200. PubMed ID: 19998479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Commercial support of continuing medical education in the United States: the politics of doubt, the value of studies.
    Mazmanian PE
    J Contin Educ Health Prof; 2009; 29(2):81-3. PubMed ID: 19530200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions between physicians and the pharmaceutical industry: what does the literature say?
    Lexchin J
    CMAJ; 1993 Nov; 149(10):1401-7. PubMed ID: 8221424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medical education and communication companies involved in CME: an updated profile.
    Peterson ED; Overstreet KM; Parochka JN; Lemon MR
    J Contin Educ Health Prof; 2008; 28(4):205-13, quiz 213-9. PubMed ID: 19058242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A risk stratification tool to assess commercial influences on continuing medical education.
    Barnes BE; Cole JG; King CT; Zukowski R; Allgier-Baker T; Rubio DM; Thorndyke LE
    J Contin Educ Health Prof; 2007; 27(4):234-40. PubMed ID: 18085603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparative evaluation of sponsored and unsponsored continuing medical education].
    Chon SH; Lösche P; Christ H; Lehmacher W; Griebenow R
    Med Klin (Munich); 2008 May; 103(5):341-5. PubMed ID: 18484220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accreditation for learning and change: quality and improvement as the outcome.
    Regnier K; Kopelow M; Lane D; Alden E
    J Contin Educ Health Prof; 2005; 25(3):174-82. PubMed ID: 16173052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Commercial support and continuing medical education.
    Steinbrook R
    N Engl J Med; 2005 Feb; 352(6):534-5. PubMed ID: 15703417
    [No Abstract]   [Full Text] [Related]  

  • 12. CME, physicians, and Pavlov: can we change what happens when industry rings the bell?
    Lichter PR
    Trans Am Ophthalmol Soc; 2008; 106():39-43; discussion 44-5. PubMed ID: 19277219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Continuing Medical Education at U.S. Medical Schools and Other Accredited Organizations: A 20-Year Analysis.
    Rayburn WF; Regnier K; McMahon GT
    Acad Med; 2020 Apr; 95(4):623-628. PubMed ID: 31626001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Conflict of interest in continuing medical education - Studies on certified CME courses].
    Lenzen LM; Weidringer JW; Ollenschläger G
    Z Evid Fortbild Qual Gesundhwes; 2016; 110-111():60-8. PubMed ID: 26875037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The medical-industrial complex, professional medical associations, and continuing medical education.
    Schofferman J
    Pain Med; 2011 Dec; 12(12):1713-9. PubMed ID: 22145759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conflict of interest.
    Richard Conti C
    Clin Cardiol; 2009 Dec; 32(12):666-7. PubMed ID: 20027665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of industry support on participants' perceptions of bias in continuing medical education.
    Kawczak S; Carey W; Lopez R; Jackman D
    Acad Med; 2010 Jan; 85(1):80-4. PubMed ID: 20042829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmaceutical industry support for continuing medical education programs: a review of current ethical guidelines.
    Rosner F
    Mt Sinai J Med; 1995 Nov; 62(6):427-30. PubMed ID: 8692156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CME/CNE Article: A Framework of Care in Multiple Sclerosis, Part 1: Updated Disease Classification and Disease-Modifying Therapy Use in Specific Circumstances.
    Newsome SD; Aliotta PJ; Bainbridge J; Bennett SE; Cutter G; Fenton K; Lublin F; Northrop D; Rintell D; Walker BD; Weigel M; Zackowski K; Jones DE
    Int J MS Care; 2016; 18(6):314-323. PubMed ID: 27999526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low rates of reporting commercial bias by physicians following online continuing medical education activities.
    Ellison JA; Hennekens CH; Wang J; Lundberg GD; Sulkes D
    Am J Med; 2009 Sep; 122(9):875-8. PubMed ID: 19699386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.